The BRAF And MEK Inhibitors Dabrafenib And Trametinib: Effects On Immune Function And In Combination With Immunomodulatory Antibodies Targeting PD-1, PD-L1, And CTLA-4
Li Liu, Patrick A. Mayes, Stephen Eastman, Hong Shi, Sapna Yadavilli, Tianqian Zhang, Jingsong Yang, Laura Seestaller-Wehr, Shu-Yun Zhang, Chris Hopson, Lyuben Tsvetkov, Junping Jing, Shu Zhang, James Smothers, Axel Hoos
Twitter
Facebook
LinkedIn
Email